The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Chronic Opioid Use in Rheumatoid Arthritis: Prevalence & Predictors

Chronic Opioid Use in Rheumatoid Arthritis: Prevalence & Predictors

May 1, 2019 • By Arthritis & Rheumatology

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Over the past decade, physicians, patients and policy makers have expressed increasing concern about the high frequency of opioids being prescribed and the association between opioid use and poor outcomes. Rates of opioid prescriptions in the general population rose considerably from the 1990s through 2010, with a plateau in the early 2010s. In 2015, 38% of U.S. adults reported using opioids, and, of these individuals, 17% had an opioid use disorder. Compared with other medications for chronic pain (e.g., anticonvulsants, tricyclic antidepressants), opioids are associated with significantly increased risk of overdose-related mortality, as well as non-overdose deaths, particularly cardiovascular deaths.

You Might Also Like
  • Study Finds Chronic Opioid Use Doubled in Rheumatoid Arthritis Patients
  • Medical Cannabis Helps Chronic Pain Patients Cut Opioid Use
  • Opioid Use in U.S. RA Patients

The opioid epidemic is a major public health concern. However, little is known about opioid use among rheumatoid arthritis (RA) patients. The authors of this study set out to examine trends in chronic opioid use in RA patients in 2002–2015 and to identify clinical predictors.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Methods: RA patients were identified from the Corrona registry, which is supported by AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Crescendo, Eli Lilly, Genentech, GlaxoSmithKline, Horizon Pharma, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer, Roche and UCB. Opioid use was ascertained from surveys obtained at clinical visits as often as every three months. Chronic opioid use was defined as any opioid use reported during two or more consecutive study visits. Annual prevalence of chronic opioid use was calculated using data from 33,739 RA patients with information on opioid use from two or more visits. Among the 26,288 individuals who were not taking opioids at baseline, Cox proportional hazards models identified associations between patient characteristics and incident chronic opioid use.

Results: Chronic opioid use increased from 7.4% in 2002 to 16.9% in 2015. Severe pain (HR 2.53 [95% CI 2.19–2.92]) and antidepressant use (HR 1.79 [95% CI 1.64–1.92]) were associated with an increased risk of chronic opioid use. High disease activity (HR 1.55 [95% CI 1.30–1.84]) and a high level of disability (HR 1.45 [95% CI 1.27–1.65]) were also associated with chronic opioid use. Medicaid insurance (HR 1.30 [95% CI 1.09–1.55]), and Medicare insurance (HR 1.27 [95% CI 1.12–1.44]) were also significantly associated with incident chronic opioid use. In addition, medications for RA, specifically glucocorticoids (HR 1.14 [95% CI 1.04–1.25]) and a number of previous DMARDs (HR 1.08 [95% CI 1.04–1.11]), were associated with a risk of incident chronic opioid use. Conversely, Asian ethnicity (HR 0.49 [95% CI 0.36–0.68]) was associated with a decreased risk of chronic opioid use.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Conclusion: Among RA patients, chronic opioid use doubled from 2002 to 2015. Pain and antidepressant use were the strongest predictors of chronic opioid use. To curb the rise in chronic opioid use, strategies for stringent control of RA disease activity and management of pain and depression should be research priorities.

Pages: 1 2 | Single Page

Filed Under: Analgesics, Drug Updates Tagged With: Arthritis & Rheumatology, Chronic pain, Opioids, Rheumatoid Arthritis (RA)

You Might Also Like:
  • Study Finds Chronic Opioid Use Doubled in Rheumatoid Arthritis Patients
  • Medical Cannabis Helps Chronic Pain Patients Cut Opioid Use
  • Opioid Use in U.S. RA Patients
  • Opioids No Better Than NSAIDs for Chronic Back or Arthritis Pain

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)